Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,137Revenue $M730Net Margin (%)8.8Altman Z-Score54.5
Enterprise Value $M19,250EPS $1.1Operating Margin %13.2Piotroski F-Score5
P/E(ttm)292Beneish M-Score-0.6Pre-tax Margin (%)13.3Higher ROA y-yN
Price/Book22.510-y EBITDA Growth Rate %--Quick Ratio5.3Cash flow > EarningsY
Price/Sales25.15-y EBITDA Growth Rate %--Current Ratio5.5Lower Leverage y-yY
Price/Free Cash Flow196y-y EBITDA Growth Rate %-35.7ROA % (ttm)7.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)9.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M76.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PCYC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCYCMario Gabelli 2015-03-31 Buy 0.04%$119.85 - $258.35
($193.06)
$ 261.2535%New holding27,750
PCYCJoel Greenblatt 2015-03-31 Sold Out -0.0026%$119.85 - $258.35
($193.06)
$ 261.2535%Sold Out0
PCYCKen Fisher 2015-03-31 Sold Out -0.0008%$119.85 - $258.35
($193.06)
$ 261.2535%Sold Out0
PCYCJoel Greenblatt 2014-12-31 Buy $103.79 - $141.55
($128.16)
$ 261.25104%New holding2,619
PCYCJoel Greenblatt 2014-09-30 Sold Out -0.09%$91.5 - $127.81
($114.49)
$ 261.25128%Sold Out0
PCYCKen Fisher 2014-09-30 Reduce$91.5 - $127.81
($114.49)
$ 261.25128%Reduce 36.57%3,244
PCYCJoel Greenblatt 2014-06-30 Add0.08%$85.85 - $107.42
($93.89)
$ 261.25178%Add 724.62%79,089
PCYCMariko Gordon 2014-06-30 Sold Out -0.04%$85.85 - $107.42
($93.89)
$ 261.25178%Sold Out0
PCYCKen Fisher 2014-06-30 Buy $85.85 - $107.42
($93.89)
$ 261.25178%New holding5,114
PCYCMariko Gordon 2014-03-31 Add0.02%$100.49 - $151.61
($129.71)
$ 261.25101%Add 112.41%9,295
PCYCJoel Greenblatt 2014-03-31 Buy 0.01%$100.49 - $151.61
($129.71)
$ 261.25101%New holding9,591
PCYCMariko Gordon 2013-12-31 Add0.01%$99.28 - $139.59
($121.32)
$ 261.25115%Add 130.07%4,376
PCYCMariko Gordon 2013-09-30 Buy 0.01%$84.5 - $132.49
($110.93)
$ 261.25136%New holding1,902
PCYCJoel Greenblatt 2013-03-31 Sold Out -0.14%$57.78 - $94.2
($77.47)
$ 261.25237%Sold Out0
PCYCJoel Greenblatt 2012-12-31 Buy 0.14%$47.87 - $69.78
($58.72)
$ 261.25345%New holding41,832
PCYCGeorge Soros 2012-06-30 Sold Out -0.04%$25.72 - $53.44
($32.62)
$ 261.25701%Sold Out0
PCYCGeorge Soros 2012-03-31 Buy 0.04%$14.99 - $28.68
($20.91)
$ 261.251149%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCYC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PCYC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Soni Manmeet SinghCFO 2015-03-13Sell27,514$254.242.76view
Tan HeowChief Quality&Tech Operations 2015-03-12Sell1,000$254.512.65view
Zanganeh MakyCOO 2015-03-11Sell30,000$254.112.81view
Zanganeh MakyCOO 2015-03-11Sell30,000$254.112.81view
Fardis MariaChief of Oncology Ops & Allian 2014-11-13Sell3,000$141.384.89view
Soni Manmeet SinghCFO 2014-11-13Sell1,000$141.4484.71view
Zanganeh MakyCOO 2014-11-12Sell30,482$134.6993.96view
Love Richard BGeneral Counsel 2014-11-10Sell1,500$133.8795.15view
Fardis MariaChief of Oncology Ops & Allian 2014-11-07Sell5,000$134.594.24view
Zanganeh MakyCOO 2014-09-04Sell12,000$121.75114.58view

Press Releases about PCYC :

    Quarterly/Annual Reports about PCYC:

    News about PCYC:

    Articles On GuruFocus.com
    AbbVie Floats Mega-Bond Deal For Acquisition Funding May 08 2015 
    Wall Street’s Best and Worst Calls of the First Quarter 2015 May 07 2015 
    Pharmacyclics Posts A Mixed First Quarter Ahead Of Being Acquired By AbbVie May 07 2015 
    AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board Apr 24 2015 
    Weekly Insider Sells Highlight: PCYC, DIS, AZO, SCI Mar 17 2015 
    AbbVie Strikes The Biggest Deal For Treatment Of Cancer Mar 10 2015 
    AbbVie To Acquire Biopharmaceutical Firm Pharmacyclics Mar 06 2015 
    own Mar 02 2015 
    Weekly 52-Week Highs Highlight: DG, AGN, ADSK, AVGO, PCYC Feb 22 2015 
    Weekly Insider Sells Highlight: BX, PCYC, MAS, ITMN Mar 03 2014 

    More From Other Websites
    AbbVie Accelerates Share Buybacks May 27 2015
    This Self-Taught Investor Is Now Running the Best-Performing Stock Fund May 26 2015
    Ambarella Leads 3 Top Stocks Bucking The Sell-Off May 26 2015
    Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog May 26 2015
    Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck May 26 2015
    Abbvie completes $21 billion buyout of Pharmacyclics May 26 2015
    Abbvie completes $21 billion buyout of Pharmacyclics May 26 2015
    PHARMACYCLICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of... May 26 2015
    AbbVie Completes Acquisition of Pharmacyclics May 26 2015
    The Most Loved Biotechs of Big Hedge Funds May 23 2015
    European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA®... May 22 2015
    Abbvie specifies breakdown of $21 billion Pharmacyclics deal May 21 2015
    Abbvie specifies breakdown of $21 billion Pharmacyclics deal May 21 2015
    AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics May 21 2015
    Pharmacyclics (PCYC), DIRECTV (DTV), Actavis (ACT): Farallon Capital Betting On Merger Arb Plays May 19 2015
    AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. May 15 2015
    New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO)... May 13 2015
    Borrowers warned: Don't be fooled by high grade market resilience May 11 2015
    Borrowers warned: Don't be fooled by high grade market resilience May 11 2015
    Basics of the IGATE–Capgemini Transaction May 08 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK